Schrander-van der Meer A M, Vogten A J
Spaarne Ziekenhuis, loc. Heemstede, Netherlands.
Neth J Med. 1992 Apr;40(3-4):183-9.
In 25 randomly selected, non-alcohol-induced cirrhotics, a simple mathematical model originally designed as the "Mayo-model" for the prediction of prognosis and survival in patients with primary biliary cirrhosis, was applied using a newly developed computer program. The calculated risk scores were 4.91 for surviving patients compared to 7.65 for those who died (P less than 0.001). The survival probability at the end of the follow-up period was 88% vs 47% (P less than 0.001) for these two groups. In 12 patients of the total of 25, multiple values were calculated at yearly intervals. Usually these R values increased except in one patient with chronic active hepatitis treated effectively with corticosteroids, and for 2 others during the correction of vitamin K deficiency. Our data suggest that this model, originally designed for and validated in patients with primary biliary cirrhosis, may also be applied to predict survival in other non-alcohol-induced cirrhotics and therefore may be applicable in prospective controlled trials in cirrhotics or in evaluating the need for and the timing of liver transplantation in the (near) future in these patients.
在25例随机选取的非酒精性肝硬化患者中,使用一个新开发的计算机程序,应用了最初设计为“梅奥模型”的简单数学模型来预测原发性胆汁性肝硬化患者的预后和生存情况。存活患者的计算风险评分为4.91,而死亡患者为7.65(P<0.001)。这两组患者在随访期末的生存概率分别为88%和47%(P<0.001)。在25例患者中的12例,每年计算多个数值。通常这些R值会升高,但有1例接受皮质类固醇有效治疗的慢性活动性肝炎患者以及另外2例在纠正维生素K缺乏期间的患者除外。我们的数据表明,这个最初为原发性胆汁性肝硬化患者设计并验证的模型,也可用于预测其他非酒精性肝硬化患者的生存情况,因此可能适用于肝硬化患者的前瞻性对照试验,或用于评估这些患者(近期)肝移植的必要性和时机。